SARS-CoV-2 and COVID-19 Research
Moving in JAMA.
- Moved, week to 22 Oct 2026
- 1
- Papers in 60 days
- 36
Rebuilt
Moved this week
Latest in SARS-CoV-2 and COVID-19 Research
Newest first · last 60 days
Genetic variation in HLA, IGKV, and HHEX loci significantly influences COVID-19 vaccine-induced neutralizing antibody responses and protection, with HLA linked to reduced breakthrough infections.
- Open access
Apt-E-36-3, a 30-mer DNA aptainhibitor, binds the SARS-CoV-2 E protein with nanomolar affinity and blocks its oligomerization, offering a potential therapeutic approach.
- Open access
Mutations in RSV F protein influence antibody neutralization, with resistance mutations emerging sporadically but remaining rare in circulating strains.
- Open access
Hedgehog aminopeptidase N (APN) acts as a functional receptor for European and Asian hedgehog merbecoviruses, with a distinct binding mode revealed by cryo-EM analysis.
- Open access
A BAC-based non-infectious SARS-CoV-2 replicon identified the M gene as a promising antisense target with an EC50 of 6.3 nM for antiviral development.
- Open access
Browse JClub
Journals this month
- bioRxiv6117
- medRxiv1746
- PNAS447
- Sci Adv354
- JAMA268
- Environ Res246
- BMJ196
- Nat Commun173
- Environ Pollution167
- Nature151
- Science141
- Lancet128
- Cell Rep127
- NEJM118
- Plant Cell Environ114
- Applied & Environ Microbio112
- Curr Biol106
- Blood105
Topics moving, week to 22 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Cancer Immunotherapy and Biomarkers5
- Gut microbiota and health5
- Cancer Genomics and Diagnostics4
- Bacteriophages and microbial interactions4
- CAR-T cell therapy research3
- Lung Cancer Treatments and Mutations3
- Liver Disease Diagnosis and Treatment3
- Dementia and Cognitive Impairment Research3
